Objective: To explore the knowledge and prevalence of menopausal symptoms as well as the use and attitude toward hormone replacement therapy (HRT) in Chinese women. Methods: A cross-sectional study was conducted between May 2011 and April 2012 in Shanghai, China. The structured questionnaire addressing sociodemographic characteristics, knowledge and prevalence of menopausal symptoms, and knowledge and attitude towards HRT and its use were investigated. Results: 3,619 women aged 40-65 years were included in the analysis. The majority of the women had knowledge of menopause. Symptoms were prevalent in 16.1% of premenopausal women and in 49.3% of peri-, post- and surgical-menopausal women. Back and joint pain, sleeplessness, fatigue and sweating/hot flushes were frequently reported. HRT awareness among women was 3.5% and was related to menopausal, working and marital status; 75 (2.1%) women had used or were using HRT, of which 57.3% used HRT with a doctor's prescription and 29.3% experienced side effects from the use of HRT. Conclusion: Most Chinese women had knowledge of menopause and thought menopausal symptoms should not be treated. The awareness of HRT was poor and influenced by menopausal, working and marital status. Chinese health care providers have to assume responsibility for educating women about menopause and HRT use.

Keywords:
Chinese women, Hormone replacement therapy, Menopause, Menopausal knowledge, Menopausal symptoms
1.
Cao ZY: Chinese Obstetrics and Gynecology. Beijing, People's Medical Publishing House, 2005.
2.
Prendergast A, Bwakura-Dangarembizi M, Cook A, et al: Hospitalisation for severe malnutrition amongst HIV-infected children starting antiretroviral therapy in the ARROW trial. Aids 2011;25:951-956.
3.
Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT: Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 1993;168:772-780.
4.
Graziottin A, Leiblum SR: Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J Sex Med 2005;2(suppl 3):133-145.
5.
Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ: Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999;130:545-553.
6.
Hunt K, Vessey M, McPherson K: Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 1990;97:1080-1086.
7.
Harlap S: The benefits and risks of hormone replacement therapy: an epidemiologic overview. Am J Obstet Gynecol 1992;166:1986-1992.
8.
Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
9.
Seo SK, Yang HI, Lim KJ, et al: Changes in serum levels of cartilage oligomeric matrix protein after estrogen and alendronate therapy in postmenopausal women. Gynecol Obstet Invest 2012;74:143-150.
10.
Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
11.
Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
12.
Majumdar SR, Almasi EA, Stafford RS: Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA 2004;292:1983-1988.
13.
Kang BM, Kim MR, Park HM, et al: Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study. Menopause 2006;13:125-129.
14.
Heinemann K, Rubig A, Strothmann A, Nahum GG, Heinemann LA: Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents. J Womens Health (Larchmt) 2008;17:1151-1166.
15.
Manson JE, Chlebowski RT, Stefanick ML, et al: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310:1353-1368.
16.
Ettinger B, Wang SM, Leslie RS, et al: Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause 2012;19:610-615.
17.
Tao M, Teng Y, Shao H, Wu P, Mills EJ: Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One 2011;6:e24661.
18.
Huang KE, Xu L, I NN, Jaisamrarn U: The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010;65:276-283.
19.
Genazzani AR, Schneider HP, Panay N, Nijland EA: The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 2006;22:369-375.
20.
Buhling KJ, Daniels BV, Studnitz FS, Eulenburg C, Mueck AO: The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years. Complement Ther Med 2014;22:94-98.
21.
Malik HS: Knowledge and attitude towards menopause and hormone replacement therapy (HRT) among postmenopausal women. J Pak Med Assoc 2008;58:164-167.
22.
Bener A, Rizk DE, Shaheen H, Micallef R, Osman N, Dunn EV: Measurement-specific quality-of-life satisfaction during the menopause in an Arabian Gulf country. Climacteric 2000;3:43-49.
23.
Kaur S, Walia I, Singh A: How menopause affects the lives of women in suburban Chandigarh, India. Climacteric 2004;7:175-180.
24.
Lam PM, Leung TN, Haines C, Chung TK: Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years. Maturitas 2003;45:99-107.
25.
Strothmann A, Schneider HP: Hormone therapy: the European women's perspective. Climacteric 2003;6:337-346.
26.
Lindh-Astrand L, Brynhildsen J, Hoffmann M, Kjellgren KI, Hammar M: Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: a population-based study. Menopause 2007;14:1039-1046.
27.
Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S: Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 2007;56:420-428.
28.
Hu Q, Li C, Tian F: Domestic Research of social health education to patients with diabetes: a systematic review. J Jishou Univ 2009;30:118-121.
29.
Marjoribanks J, Farquhar C, Roberts H, Lethaby A: Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2012;7: CD004143.
30.
Rozenberg S, Vandromme J, Antoine C: Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol 2013;9:216-227.
31.
Heinemann K, Ruebig A, Potthoff P, et al: The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004;2:45.
32.
Perrone G, Capri O, Galoppi P, et al: Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up. Gynecol Obstet Invest 2013;76:38-43.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.